Evidence map›Paper›PMID 26542706›Full record

ArticleDisease models & mechanisms2015

The goya mouse mutant reveals distinct newly identified roles for MAP3K1 in the development and survival of cochlear sensory hair cells.

Andrew Parker, Sally H Cross, Ian J Jackson, Rachel Hardisty-Hughes, Susan Morse, George Nicholson, Emma Coghill, Michael R Bowl, Steve D M Brown

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. The role of post-translational modifications in hearing and deafness.Cellular and molecular life sciences : CMLS · 2016
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andrew ParkerMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK.
Sally H CrossMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Ian J JacksonMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, EH4 2XU, UK The Roslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK.
Rachel Hardisty-HughesMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK.
Susan MorseMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK.
George NicholsonMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK Department of Statistics, University of Oxford, Oxford, OX1 3TG, UK.
Emma CoghillMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK.
Michael R BowlMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK.
Steve D M BrownMRC Mammalian Genetics Unit, MRC Harwell, Oxford, OX11 0RD, UK s.brown@har.mrc.ac.uk.
Mary Lyon Centre at MRC Harwell · GBMRC Institute of Genetics and Molecular Medicine · GB

Funding

Medical Research Council MC_A390_5RX80Medical Research Council MC_PC_U127561112Medical Research Council MC_U142684172Medical Research Council MC_U142684175Wellcome Trust
6 · The paper itself

Abstract

Mitogen-activated protein kinase, MAP3K1, plays an important role in a number of cellular processes, including epithelial migration during eye organogenesis. In addition, studies in keratinocytes indicate that MAP3K1 signalling through JNK is important for actin stress fibre formation and cell migration. However, MAP3K1 can also act independently of JNK in the regulation of cell proliferation and apoptosis. We have identified a mouse mutant, goya, which exhibits the eyes-open-at-birth and microphthalmia phenotypes. In addition, these mice also have hearing loss. The goya mice carry a splice site mutation in the Map3k1 gene. We show that goya and kinase-deficient Map3k1 homozygotes initially develop supernumerary cochlear outer hair cells (OHCs) that subsequently degenerate, and a progressive profound hearing loss is observed by 9 weeks of age. Heterozygote mice also develop supernumerary OHCs, but no cellular degeneration or hearing loss is observed. MAP3K1 is expressed in a number of inner-ear cell types, including outer and inner hair cells, stria vascularis and spiral ganglion. Investigation of targets downstream of MAP3K1 identified an increase in p38 phosphorylation (Thr180/Tyr182) in multiple cochlear tissues. We also show that the extra OHCs do not arise from aberrant control of proliferation via p27KIP1. The identification of the goya mutant reveals a signalling molecule involved with hair-cell development and survival. Mammalian hair cells do not have the ability to regenerate after damage, which can lead to irreversible sensorineural hearing loss. Given the observed goya phenotype, and the many diverse cellular processes that MAP3K1 is known to act upon, further investigation of this model might help to elaborate upon the mechanisms underlying sensory hair cell specification, and pathways important for their survival. In addition, MAP3K1 is revealed as a new candidate gene for human sensorineural hearing loss.

Indexed as

AnimalsBase Sequencebeta-GalactosidaseCell ProliferationCell SurvivalCyclin-Dependent Kinase Inhibitor p27FemaleHair Cells, Auditory, OuterHearingHearing LossMaleMAP Kinase Kinase Kinase 1Mice, Inbred C57BLMice, Mutant StrainsMolecular Sequence Datap38 Mitogen-Activated Protein Kinasesbeta-GalactosidaseCyclin-Dependent Kinase Inhibitor p27Map3k1 protein, mouseMAP Kinase Kinase Kinase 1p38 Mitogen-Activated Protein KinasesCochlear developmentHearing lossMAP3K1Sensory hair cell survivalSupernumerary outer hair cells

Identifiers

PMID26542706
PMCPMC4728324
OpenAlexW2194994304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.